Notch Signaling in CBS/PSP
Overview
Notch signaling is a highly conserved pathway that plays critical roles in neural development, adult neurogenesis, and cellular differentiation. In corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP), both classified as 4-repeat (4R) tauopathies, dysregulation of Notch signaling contributes to neuronal vulnerability and impaired repair mechanisms. This section examines Notch pathway alterations in CBS/PSP and their relationship to tau pathology. [@armstrong2020]
CBS and PSP share common pathological features of 4R tau accumulation, but exhibit distinct clinical presentations [1](https://doi.org/10.1016/S1474-4422(22)00087-0). While CBS presents with asymmetric cortical dysfunction and basal ganglia degeneration leading to apraxia, alien limb phenomena, and cortical sensory loss, PSP is characterized by vertical gaze palsy, postural instability, and axial rigidity with progressive gait disturbance. Notch signaling interacts with tau pathology through multiple mechanisms, including regulation of tau phosphorylation, modulation of neurogenesis, and control of glial cell function. Understanding these interactions may reveal novel therapeutic targets for disease modification. [@litvan2020]
...Notch Signaling in CBS/PSP
Overview
Notch signaling is a highly conserved pathway that plays critical roles in neural development, adult neurogenesis, and cellular differentiation. In corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP), both classified as 4-repeat (4R) tauopathies, dysregulation of Notch signaling contributes to neuronal vulnerability and impaired repair mechanisms. This section examines Notch pathway alterations in CBS/PSP and their relationship to tau pathology. [@armstrong2020]
CBS and PSP share common pathological features of 4R tau accumulation, but exhibit distinct clinical presentations [1](https://doi.org/10.1016/S1474-4422(22)00087-0). While CBS presents with asymmetric cortical dysfunction and basal ganglia degeneration leading to apraxia, alien limb phenomena, and cortical sensory loss, PSP is characterized by vertical gaze palsy, postural instability, and axial rigidity with progressive gait disturbance. Notch signaling interacts with tau pathology through multiple mechanisms, including regulation of tau phosphorylation, modulation of neurogenesis, and control of glial cell function. Understanding these interactions may reveal novel therapeutic targets for disease modification. [@litvan2020]
The Notch pathway's role in neurodegeneration extends beyond its developmental functions. In the adult brain, Notch signaling regulates neural stem cell populations, modulates synaptic plasticity, and influences glial cell function. Dysregulation of these processes contributes to the progressive neurodegeneration observed in both CBS and PSP. [@boxer2020]
The Notch Signaling Pathway
Notch Receptors and Ligands
The Notch family includes multiple receptors and ligands with distinct expression patterns [2](https://doi.org/10.1016/j.tins.2020.09.004): [@kovacs2022]
Notch Receptors: [@williams2021]
- Notch1: Widely expressed throughout the brain, critical for neuronal function
- Notch2: Expressed in neurons and glia, important for glial development
- Notch3: Prominent in vascular cells and pericytes, affects blood-brain barrier
- Notch4: Lower expression in CNS, primarily in endothelial cells
Notch Ligands (DSL family): [@stamelou2021]
- Delta-like (DLL1, DLL3, DLL4): Membrane-bound ligands with distinct functions
- Jagged (JAG1, JAG2): Alternative ligands with context-dependent effects
The ligands are transmembrane proteins requiring cell-cell contact for Notch activation. This contact-dependent signaling allows precise spatial regulation of Notch activity in the brain. [@chahine2020]
Signal Transduction
The Notch pathway involves sequential proteolytic cleavage: [@jellinger2020]
Mermaid diagram (expand to render)
Canonical pathway steps: [@mandelkow2010]
Ligand binding: DLL or JAG binds to Notch extracellular domain
ADAM cleavage: TACE (TNF-alpha-converting enzyme) cleaves the extracellular domain
gamma-secretase cleavage: intramembrane proteolysis releases Notch intracellular domain (NICD)
Nuclear translocation: NICD translocates to nucleus
Transcriptional activation: NICD binds CSL (CBF1/RBP-Jkappa/Su(H)/LAG-1) complexDownstream targets: Hes (Hairy and Enhancer of Split) and Hey (Hairy/Enhancer-of-Split related with YRPW motif) transcription factors regulate genes involved in differentiation, proliferation, and survival [@mckinnon2020]
Notch in Normal Brain Function
Adult Neurogenesis
Notch signaling plays essential roles in adult neurogenesis [3](https://doi.org/10.1016/j.tins.2020.09.004):
- Neural stem cell maintenance: Notch maintains the progenitor cell pool in subventricular zone and dentate gyrus
- Neuronal differentiation: Temporal regulation of neurogenesis controls the transition from proliferation to differentiation
- Glial specification: Notch controls the choice between astrocyte and oligodendrocyte lineage
The balance between Notch activation and inhibition determines whether neural stem cells remain proliferative or differentiate into neurons. This balance is critical for ongoing neurogenesis in the adult brain.
Synaptic Function
Notch contributes to synaptic plasticity through multiple mechanisms [4](https://doi.org/10.1016/j.neuroscience.2018.04.012):
- Presynaptic function: Notch regulates neurotransmitter release and vesicle cycling
- Postsynaptic density: Modulates receptor trafficking and synaptic protein synthesis
- Learning and memory: Notch activity in hippocampal neurons is required for memory consolidation
- Dendritic spine morphology: Controls spine formation and maintenance
Notch receptors are present at both excitatory and inhibitory synapses, where they modulate synaptic strength and plasticity through interactions with postsynaptic density proteins.
Glial Function
Notch signaling regulates glial cell types:
- Astrocytes: Notch influences astrocyte differentiation and reactivity
- Oligodendrocytes: Controls oligodendrocyte progenitor cell proliferation and differentiation
- Microglia: Modulates microglial activation states and inflammatory responses
- Schwann cells: Peripheral nervous system myelination
Notch Dysregulation in CBS/PSP
Altered Pathway Activity
Studies suggest Notch pathway alterations in tauopathies [5](https://doi.org/10.1007/s00401-020-02171-5):
Dysregulated Notch expression: Altered receptor and ligand levels in affected brain regions
Impaired cleavage: Changes in ADAM and γ-secretase activity affecting pathway activation
Nuclear signaling: Altered Hes/Hey target gene expression patterns
Relationship to tau: Notch changes correlate with 4R tau burdenThe motor cortex and basal ganglia, regions prominently affected in CBS, show particular Notch pathway alterations. Immunohistochemical studies demonstrate changes in Notch immunoreactivity in neurons with tau inclusions.
Notch-Tau Interactions
Notch signaling interacts with tau pathology in complex ways [6](https://doi.org/10.1186/s40478-014-0012-0):
- Tau phosphorylation: Notch can influence kinase pathways that phosphorylate tau
- Neurogenesis impairment: Reduced Notch signaling impairs neural repair mechanisms
- Neuronal vulnerability: Loss of Notch-mediated survival signals increases susceptibility to tau-induced death
- Synaptic dysfunction: Notch dysregulation contributes to synaptic loss
The relationship between Notch signaling and tau creates a vicious cycle: tau pathology impairs Notch signaling, which reduces neuroprotection and neurogenesis, leading to further tau accumulation and spread.
Regional Vulnerability
The pattern of Notch dysregulation in CBS/PSP follows the regional distribution of tau pathology:
- Motor cortex: Severe Notch pathway impairment in CBS
- Basal ganglia: Altered signaling in both CBS and PSP
- Hippocampus: Changes affecting memory and cognitive function
- Substantia nigra: Loss of Notch-mediated dopaminergic neuron survival
Therapeutic Implications
Targeting Notch
Therapeutic strategies targeting Notch signaling include [7](https://doi.org/10.1038/s41573-020-0089-1):
- γ-Secretase modulators: Selective pathway modulation rather than complete inhibition
- Notch antibodies: Receptor-targeted approaches
- DLL/JAG antagonists: Blocking excessive activation
- Hes/Hey inhibitors: Downstream target modulation
Clinical Considerations
Challenges in Notch-targeted therapy [8](https://doi.org/10.1016/j.tcb.2020.06.002):
- Developmental effects: Notch is essential for development; complete inhibition problematic
- BBB penetration: CNS delivery considerations for large molecules
- Selectivity: Avoiding effects on multiple Notch receptors
- Timing: Optimal intervention point may vary by disease stage
Promising approaches include:
- Brain-penetrant γ-secretase modulators
- Receptor-specific antibodies
- Small molecule inhibitors of downstream targets
Cross-Links to Related Pages
- [Notch Signaling in Neurodegeneration](/mechanisms/notch-signaling-neurodegeneration) — General pathway overview
- [Notch Signaling in Parkinson's Disease](/mechanisms/notch-signaling-parkinsons) — Synucleinopathy comparison
- [Gamma-Secretase in Neurodegeneration](/mechanisms/gamma-secretase-pathway) — Proteolytic processing
- [Neurogenesis in Neurodegeneration](/mechanisms/neurogenesis-neurodegeneration) — Notch in neural stem cells
- [Synaptic Dysfunction in CBS](/mechanisms/cbs-synaptic-dysfunction) — Notch at synapses
- [4R Tauopathy Mechanisms](/mechanisms/4r-tau-cbs) — Tau isoform interactions
- [Neuroinflammation in CBS](/mechanisms/cbs-neuroinflammation) — Notch modulation of glia